Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1111-1120 of 1,835) with videos related to

Pageof 184
Sort By:
Mabs|June 12, 2021
Identifying biophysical assays and <i>in silico</i> properties that enrich for slow clearance in clinical-stage therapeutic antibodiesBoris Grinshpun, Nels Thorsteinson, Joao Ns Pereira, et al.
Mabs|April 17, 2015
Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1Gang Chen, Leonid Gorelik, Kenneth J Simon, et al.
Mabs|July 21, 2020
COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumorsAnand Panchal, Pui Seto, Russell Wall, et al.
Mabs|April 14, 2023
Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality controlFeng Yang, Jennifer Zhang, Alexander Buettner, et al.
Mabs|May 10, 2023
VERITAS: Harnessing the power of nomenclature in biologic discoveryRiti Biswas, Ed Belouski, Kevin Graham, et al.
Mabs|May 27, 2014
Characterization of a quantitative method to measure free proprotein convertase subtilisin/kexin type 9 in human serumAlexander Colbert, Amber Umble-Romero, Samantha Prokop, et al.
Mabs|August 18, 2020
A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapyXiaoniu Miao, Yi Luo, Xi Huang, et al.
Mabs|July 10, 2020
Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectivenessDominik Brücher, Vojtech Franc, Sheena N Smith, et al.
Mabs|August 4, 2020
Affinity maturation of antibodies by combinatorial codon mutagenesis versus error-prone PCRJan Fredrik Simons, Yoong Wearn Lim, Kyle P Carter, et al.
Mabs|August 4, 2020
Bivalent binding on cells varies between anti-CD20 antibodies and is dose-dependentSina Bondza, Toine Ten Broeke, Marika Nestor, et al.
Pageof 184

Showing results (1111-1120 of 1,835) with videos related to

Sort By:
Pageof 184
Mabs|June 12, 2021
Identifying biophysical assays and <i>in silico</i> properties that enrich for slow clearance in clinical-stage therapeutic antibodiesBoris Grinshpun, Nels Thorsteinson, Joao Ns Pereira, et al.
Mabs|April 17, 2015
Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1Gang Chen, Leonid Gorelik, Kenneth J Simon, et al.
Mabs|July 21, 2020
COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumorsAnand Panchal, Pui Seto, Russell Wall, et al.
Mabs|April 14, 2023
Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality controlFeng Yang, Jennifer Zhang, Alexander Buettner, et al.
Mabs|May 10, 2023
VERITAS: Harnessing the power of nomenclature in biologic discoveryRiti Biswas, Ed Belouski, Kevin Graham, et al.
Mabs|May 27, 2014
Characterization of a quantitative method to measure free proprotein convertase subtilisin/kexin type 9 in human serumAlexander Colbert, Amber Umble-Romero, Samantha Prokop, et al.
Mabs|August 18, 2020
A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapyXiaoniu Miao, Yi Luo, Xi Huang, et al.
Mabs|July 10, 2020
Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectivenessDominik Brücher, Vojtech Franc, Sheena N Smith, et al.
Mabs|August 4, 2020
Affinity maturation of antibodies by combinatorial codon mutagenesis versus error-prone PCRJan Fredrik Simons, Yoong Wearn Lim, Kyle P Carter, et al.
Mabs|August 4, 2020
Bivalent binding on cells varies between anti-CD20 antibodies and is dose-dependentSina Bondza, Toine Ten Broeke, Marika Nestor, et al.
Pageof 184